BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 19054549)

  • 1. Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science.
    Wentzensen N; Sherman ME; Schiffman M; Wang SS
    Gynecol Oncol; 2009 Feb; 112(2):293-9. PubMed ID: 19054549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel epigenetic changes in CDKN2A are associated with progression of cervical intraepithelial neoplasia.
    Wijetunga NA; Belbin TJ; Burk RD; Whitney K; Abadi M; Greally JM; Einstein MH; Schlecht NF
    Gynecol Oncol; 2016 Sep; 142(3):566-73. PubMed ID: 27401842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Credentialing of DNA methylation assays for human genes as diagnostic biomarkers of cervical intraepithelial neoplasia in high-risk HPV positive women.
    Vasiljević N; Scibior-Bentkowska D; Brentnall AR; Cuzick J; Lorincz AT
    Gynecol Oncol; 2014 Mar; 132(3):709-14. PubMed ID: 24508839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
    Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
    Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylation analysis of the FAM19A4 gene in cervical scrapes is highly efficient in detecting cervical carcinomas and advanced CIN2/3 lesions.
    De Strooper LM; Meijer CJ; Berkhof J; Hesselink AT; Snijders PJ; Steenbergen RD; Heideman DA
    Cancer Prev Res (Phila); 2014 Dec; 7(12):1251-7. PubMed ID: 25281488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cervical cancer risk in HPV-positive women after a negative FAM19A4/mir124-2 methylation test: A post hoc analysis in the POBASCAM trial with 14 year follow-up.
    De Strooper LMA; Berkhof J; Steenbergen RDM; Lissenberg-Witte BI; Snijders PJF; Meijer CJLM; Heideman DAM
    Int J Cancer; 2018 Sep; 143(6):1541-1548. PubMed ID: 29663363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA methylation marker for the triage of hrHPV positive women in cervical cancer screening: Real-world evidence in Taiwan.
    Chang CL; Ho SC; Su YF; Juan YC; Huang CY; Chao AS; Hsu ZS; Chang CF; Fwu CW; Chang TC
    Gynecol Oncol; 2021 May; 161(2):429-435. PubMed ID: 33757653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequential gene promoter methylation during HPV-induced cervical carcinogenesis.
    Henken FE; Wilting SM; Overmeer RM; van Rietschoten JG; Nygren AO; Errami A; Schouten JP; Meijer CJ; Snijders PJ; Steenbergen RD
    Br J Cancer; 2007 Nov; 97(10):1457-64. PubMed ID: 17971771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA methylation analysis in liquid-based cytology for cervical cancer screening.
    Apostolidou S; Hadwin R; Burnell M; Jones A; Baff D; Pyndiah N; Mould T; Jacobs IJ; Beddows S; Kocjan G; Widschwendter M
    Int J Cancer; 2009 Dec; 125(12):2995-3002. PubMed ID: 19609949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation of the hsa-miR-124, SOX1, TERT, and LMX1A genes as biomarkers for precursor lesions in cervical cancer.
    Rogeri CD; Silveira HCS; Causin RL; Villa LL; Stein MD; de Carvalho AC; Arantes LMRB; Scapulatempo-Neto C; Possati-Resende JC; Antoniazzi M; Longatto-Filho A; Fregnani JHTG
    Gynecol Oncol; 2018 Sep; 150(3):545-551. PubMed ID: 29960712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of novel DNA methylation markers in cervical cancer.
    Lai HC; Lin YW; Huang TH; Yan P; Huang RL; Wang HC; Liu J; Chan MW; Chu TY; Sun CA; Chang CC; Yu MH
    Int J Cancer; 2008 Jul; 123(1):161-7. PubMed ID: 18398837
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
    Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
    Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of candidate methylation markers to detect cervical neoplasia.
    Shivapurkar N; Sherman ME; Stastny V; Echebiri C; Rader JS; Nayar R; Bonfiglio TA; Gazdar AF; Wang SS
    Gynecol Oncol; 2007 Dec; 107(3):549-53. PubMed ID: 17894941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative DNA methylation analysis of candidate genes in cervical cancer.
    Siegel EM; Riggs BM; Delmas AL; Koch A; Hakam A; Brown KD
    PLoS One; 2015; 10(3):e0122495. PubMed ID: 25826459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a multiplex methylation-specific PCR as candidate triage test for women with an HPV-positive cervical scrape.
    Snellenberg S; De Strooper LM; Hesselink AT; Meijer CJ; Snijders PJ; Heideman DA; Steenbergen RD
    BMC Cancer; 2012 Nov; 12():551. PubMed ID: 23176198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methylation markers FAM19A4 and miR124-2 as triage strategy for primary human papillomavirus screen positive women: A large European multicenter study.
    Bonde J; Floore A; Ejegod D; Vink FJ; Hesselink A; van de Ven PM; Valenčak AO; Pedersen H; Doorn S; Quint WG; Petry KU; Poljak M; Stanczuk G; Cuschieri K; de Sanjosé S; Bleeker M; Berkhof J; Meijer CJLM; Heideman DAM
    Int J Cancer; 2021 Jan; 148(2):396-405. PubMed ID: 32997803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.
    Kim JH; Choi YD; Lee JS; Lee JH; Nam JH; Choi C
    Gynecol Oncol; 2010 Jan; 116(1):99-104. PubMed ID: 19836067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of HPV 16 DNA methylation combined with E6 oncoprotein in cervical cancer screening: a 10-year prospective cohort study.
    Dong L; Zhang L; Hu SY; Feng RM; Zhao XL; Zhang Q; Pan QJ; Zhang X; Qiao YL; Zhao FH
    Clin Epigenetics; 2020 May; 12(1):62. PubMed ID: 32381054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
    Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
    Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery and validation of candidate host DNA methylation markers for detection of cervical precancer and cancer.
    Clarke MA; Luhn P; Gage JC; Bodelon C; Dunn ST; Walker J; Zuna R; Hewitt S; Killian JK; Yan L; Miller A; Schiffman M; Wentzensen N
    Int J Cancer; 2017 Aug; 141(4):701-710. PubMed ID: 28500655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.